Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

Study evaluated the effect of oral treatment with NSI-189 in well-established 5xFAD mouse model for Alzheimer’s disease (AD) Treatment with NSI-189 restored memory retention and learning abilities in AD mice, and reduced anxiety in control and AD mice GERMANTOWN, Md., July 23, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments […]

Creative Technology Opens CT Japan Office in Tokyo

TOKYO, July 22, 2018 (GLOBE NEWSWIRE) — Creative Technology (CT), a worldwide outsourced technical production partner for corporate live events and exhibition producers and an NEP Live Events Company, announced the opening of operations in Tokyo to meet the growing demand for its services in Japan. CT Japan will provide extensive audio, lighting, LED and […]